Lucas Ward
Stock Analyst at Ascendiant Capital
(0.26)
# 4,066
Out of 4,754 analysts
14
Total ratings
21.43%
Success rate
-47.88%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACON Aclarion | Maintains: Buy | $555 → $481 | $3.35 | +14,258.21% | 3 | Nov 27, 2024 | |
| LIQT LiqTech International | Maintains: Buy | $5.15 → $3.2 | $1.48 | +116.22% | 3 | Nov 25, 2024 | |
| VVOS Vivos Therapeutics | Reiterates: Buy | $6.6 | $3.47 | +90.20% | 2 | Nov 20, 2024 | |
| HSCS HeartSciences | Reiterates: Buy | $15 | $3.56 | +321.35% | 1 | Sep 23, 2024 | |
| CYTH Cyclo Therapeutics | Maintains: Buy | $2.6 → $0.95 | $0.76 | +25.02% | 2 | Aug 26, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $338 → $270 | $0.77 | +34,964.94% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $144 | $1.81 | +7,855.80% | 1 | Oct 2, 2023 |
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $3.35
Upside: +14,258.21%
LiqTech International
Nov 25, 2024
Maintains: Buy
Price Target: $5.15 → $3.2
Current: $1.48
Upside: +116.22%
Vivos Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $6.6
Current: $3.47
Upside: +90.20%
HeartSciences
Sep 23, 2024
Reiterates: Buy
Price Target: $15
Current: $3.56
Upside: +321.35%
Cyclo Therapeutics
Aug 26, 2024
Maintains: Buy
Price Target: $2.6 → $0.95
Current: $0.76
Upside: +25.02%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $338 → $270
Current: $0.77
Upside: +34,964.94%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $144
Current: $1.81
Upside: +7,855.80%